‘Superpotent’ thyroid medication recalled one month after FDA advises against similar tablets
Aug 25, 2026
Vitruvias Therapeutics says no adverse events are known to be linked to the recalled thyroid medication.
https://nypost.com/2026/08/25/us-news/thyroid-medication-recalled-one-month-after-fda-advises-against-similar-tablets/
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service